Gene · 1846
Papers1,689
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,689
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective. | Cancers (Basel) | 2023 | 38001653 | PubTator, text mining | PubMed |
| Borealin/CDCA8 deficiency alters thyroid development and results in papillary tumor-like structures. | Front Endocrinol (Lausanne) | 2023 | 37964961 | PubTator, text mining | PubMed |
| ADSC secretome constrains NK cell activity by attenuating IL-2-mediated JAK-STAT and AKT signaling pathway via upregulation of CIS and DUSP4. | Stem Cell Res Ther | 2023 | 37964351 | PubTator, text mining | PubMed |
| Comparative immunological landscape between pre- and early-stage LUAD manifested as ground-glass nodules revealed by scRNA and scTCR integrated analysis. | Cell Commun Signal | 2023 | 37957625 | PubTator, text mining | PubMed |
| Graph-based multi-modality integration for prediction of cancer subtype and severity. | Sci Rep | 2023 | 37949935 | PubTator, text mining | PubMed |
| Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis. | BMC Cancer | 2023 | 37946160 | PubTator, text mining | PubMed |
| Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment. | NPJ Regen Med | 2023 | 37935709 | PubTator, text mining | PubMed |
| Bioinformatics identification of a T-cell-related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma. | IET Syst Biol | 2023 | 37935646 | PubTator, text mining | PubMed |
| Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system. | Biomater Res | 2023 | 37932837 | PubTator, text mining | PubMed |
| Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma. | J Biol Chem | 2023 | 37923138 | PubTator, text mining | PubMed |
| DUSP8 induces TGF-β-stimulated IL-9 transcription and Th9-mediated allergic inflammation by promoting nuclear export of Pur-α. | J Clin Invest | 2023 | 37909329 | PubTator, text mining | PubMed |
| Proteomic signaling of dual specificity phosphatase 4 (DUSP4) in Alzheimer's disease. | Res Sq | 2023 | 37886598 | PubTator, text mining | PubMed |
| PHACTR1 promotes the mobility of papillary thyroid carcinoma cells by inducing F-actin formation. | Heliyon | 2023 | 37876444 | PubTator, text mining | PubMed |
| Correction: MKP2 inhibits TGF-β1-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells through a JNK-dependent pathway. | Clin Sci (Lond) | 2023 | 37860861 | PubTator, text mining | PubMed |
| Identification of disease modules using higher-order network structure. | Bioinform Adv | 2023 | 37860106 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer. | Sci Adv | 2023 | 37831779 | PubTator, text mining | PubMed |
| Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies. | Front Mol Biosci | 2023 | 37818101 | PubTator, text mining | PubMed |
| Minichromosome maintenance 6 protects against renal fibrogenesis by regulating DUSP6-mediated ERK/GSK-3β/Snail1 signaling. | iScience | 2023 | 37810227 | PubTator, text mining | PubMed |
| ERK mediates interferon gamma-induced melanoma cell death. | Mol Cancer | 2023 | 37803324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1846/papers?page=6